UROV
Urovant Sciences Ltd.
UROV
UROV
Delisted
UROV was delisted on the 26th of March, 2021.
41 hedge funds and large institutions have $99.7M invested in Urovant Sciences Ltd. in 2020 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
41
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$12.1M | |
| 2 | +$5.67M | |
| 3 | +$3.99M | |
| 4 |
GF
Gabelli Funds
Rye,
New York
|
+$3.89M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.39M |
Top Sellers
| 1 | -$9.14M | |
| 2 | -$6.41M | |
| 3 | -$5.8M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.31M |
| 5 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$1.47M |
